Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome

Europace

Volumn 14, Issue 6, 2012, Pages 882-888

  Santos, Luis Ferreira ^a   Rodrigues, Bruno ^a   Moreira, Davide ^a   Correia, Emanuel ^a   Nunes, Luis ^a   Costa, Antonio ^a   Elvas, Luis ^b   Pereira, Telmo ^c   MacHado, Jose Carlos ^d,e   Castedo, Sergio ^d,e   Henriques, Carla ^f   Matos, Ana ^f   Santos, Jorge Oliveira ^a  

^a Tondela Viseu Hospital Center ^*  (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c Superior School of Health Technology of Coimbra   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e University of Porto   (Portugal)

^f POLYTECHNIC INSTITUTE OF VISEU   (Portugal)

Author keywords

Brugada syndrome; Diagnostic criteria; ECG; SAECG; SCN5A mutation; Sudden cardiac death

Indexed keywords

SODIUM CHANNEL NAV1.5;

ADOLESCENT; ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CARDIOVASCULAR PARAMETERS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FAMILY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE; PATHOPHYSIOLOGY; PORTUGAL; PR INTERVAL; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QRS COMPLEX; SCHOOL CHILD;

ADOLESCENT; ADULT; BRUGADA SYNDROME; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FAMILY HEALTH; FEMALE; HETEROZYGOTE DETECTION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; PEDIGREE; POINT MUTATION; PORTUGAL; RIBS; SODIUM CHANNELS;

EID: 84861647580     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur421     Document Type: Article

References (15)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 1992;20:1391-6.
2. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-6.
3. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Longterm follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8.
4. Priori SG, Napolitano C, Gasparini M, Pappone C, Della-Bella P, Giordano U, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342-7.
5. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 2006;29:1130-59.
6. Akhtar M, Goldschlager NF. Brugada electrocardiographic pattern due to tricyclic antidepressant overdose. J Electrocardiol 2006;39:336-9.
7. Brugada P, Brugada R, Brugada J, Priori SG, Napolitano C Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005 112 279-92
8. Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T,WolpertCet al. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: Different incidences in familial and sporadic disease. Hum Mutat 2003;21:651-2.
9. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-70.
10. Richter S, Sarkozy A, Paparella G, Henkens S, Boussy T, Chierchia GB, et al. Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: a diagnostic consensus criterion to be revised. Eur Heart J 2010;31:1357-64.
11. Shimizu W, Matsuo K, Takagi M, Tanabe Y, Aiba T, Taquichi A, et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000;11: 396-404.
12. Meregalli PG, Tan HL, Probst V, Koopmann TT, Tansk MW, Bhuiyan ZA, et al. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm 2009;6:341-8.
13. Santos LF, Pereira T, Rodrigues B, Faria R, Correia E, Nunes L, et al. ECG and diagnosis of Brugada syndrome: can we go beyond the pattern? Portuguese J Cardiol 2010 29 47
14. Probst V, Wilde AA, Barc J, Sacher F, Babuty D, Mabo P, et al. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet 2009;2:552-7.
15. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD, et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004;110: 3023-7.